Last updated on February 2018

Ceftobiprole in the Treatment of Pediatric Patients With Pneumonia


Brief description of study

This is a study of the safety and efficacy of ceftobiprole in pediatric patients with hospital-acquired bacterial pneumonia (HAP) or community-acquired bacterial pneumonia (CAP) requiring hospitalization.

Detailed Study Description

This is a randomized, investigator-blind, active-controlled study to evaluate the safety, tolerability, pharmacokinetics and efficacy of ceftobiprole versus intravenous standard-of-care cephalosporin treatment with or without vancomycin in pediatric patients aged from 3 months to less than 18 years with HAP or CAP requiring hospitalization.

Clinical Study Identifier: NCT03439124

Contact Investigators or Research Sites near you

Start Over

Kamal Hamed, MD, MPH

Investigational Site
Torokbalint, Hungary
3.23miles
  Connect »

Kamal Hamed, MD, MPH

Investigational Site
Budapest, Hungary
9.86miles
  Connect »